Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3016018	li-diffi	— (—)	5586	8312	99.95%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Normal-pressure hydrocephalus

281

133

24.63

307.65

1.6

1.2

—

Viral infections of the central nervous system, including avohilmo

388

352

12.31

307.65

1.4

1.5

—

Viral infections of the central nervous system

369

330

12.55

307.65

1.4

1.5

—

Alzheimer disease, excluding more controls

319

114

18.68

296.90

1.2

1.1

—

Viral encephalitis, not elsewhere classified/unspecified, including avohilmo

162

28.31

229.63

1.6

—

Viral encephalitis, not elsewhere classified/unspecified

157

27.37

219.78

1.6

—

Alzheimer’s disease (Late onset), excluding more controls

210

16.45

186.76

1.2

1.1

—

Postprocedural disorders of nervous system

240

307

8.37

177.25

1.3

1.2

—

Other and unspecified hydrocephalus

125

26.34

173.76

2.6

1.4

—

Obstructive hydrocephalus

110

35.37

169.14

2.7

2.4

—

Malignant neoplasm of brain, including Hilmo

187

199

10.20

160.19

1.9

1.3

—

Infections, IBD-co-morbidities

218

153

10.23

159.72

1.8

1.6

—

Viral meningitis, including avohilmo

171

163

11.65

159.07

1.3

1.4

—

Viral meningitis

166

152

12.16

158.73

1.3

1.4

—

Traumatic subdural haemorrhage

163

131

11.89

154.30

1.8

1.1

—

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

213

279

8.12

154.00

1.8

1.3

—

Delirium, not induced by alcohol and other psychoactive substances

251

396

6.56

151.71

1.3

—

Alzheimer’s disease (Early onset), excluding more controls

103

31.84

151.19

1.1

1.0

—

Malignant neoplasm of brain

148

142

11.48

136.88

1.8

1.4

—

Dementia, including avohilmo

612

1322

3.21

136.27

1.2

1.3

—

Degenerative diseases of the nervous system

488

981

3.64

133.64

1.2

1.3

—

Tick-borne viral encephalitis, including avohilmo

58.43

133.58

1.1

1.4

—

Malignant neoplasm of eye, brain and central nervous system

161

184

9.48

130.65

1.9

1.5

—

Any dementia, excluding more controls

476

910

3.66

129.03

1.2

1.3

—

Dementia

551

1159

3.30

128.57

1.2

1.3

—

Cerebral cysts

170

214

8.44

127.16

1.4

—

Benign intracranial hypertension

32.53

125.12

1.3

1.6

—

Tick-borne viral encephalitis

63.00

119.65

1.1

1.5

—

Status epilepticus

123

118

11.23

113.35

1.9

—

Speech disturbances, not elsewhere classified

206

368

5.85

110.47

1.3

—

Other disorders of optic [2nd] nerve and visual pathways

180

284

6.72

109.92

1.7

1.8

—

Guillain-Barre syndrome

20.68

105.43

1.4

1.3

—

Any dementia

482

1084

3.12

103.39

1.2

1.3

—

Meningitis, viral

65.87

101.51

1.4

1.1

—

Anaemias

305

469

4.24

98.21

2.1

1.2

—

Disorders of thyroid, IBD co-morbidities

173

166

7.23

98.02

1.6

1.3

—

Unspecific neurodegenerative disorder

490

1148

2.96

96.20

1.1

1.3

—

Other mental disorders due to brain damage and dysfunction and to physical disease

203

414

5.06

93.66

1.3

1.4

—

Parkinson's disease, excluding more controls

115

114

9.42

92.52

1.3

1.2

—

Papilloedema, unspecified

12.19

91.42

1.6

1.5

—

Parkinson's disease, strict definition, excluding more controls

110

107

9.74

91.27

1.2

—

Use of anticholinesterases

401

1010

3.11

88.30

1.1

1.3

—

N06DA Anticholinesterases

401

1010

3.11

88.30

1.1

1.3

—

Alzheimer’s disease, strict definition

310

700

3.63

88.11

1.2

1.3

—

Memory loss

165

316

5.41

81.99

1.3

—

Alzheimer’s disease (Early onset)

103

121

8.89

81.27

1.1

1.2

—

Alzheimer disease, including avohilmo

408

976

2.93

79.10

1.2

1.3

—

Examination and observation for other reasons

688

1715

2.29

76.95

1.5

1.4

—

Other disorders of central nervous system

19.96

75.22

1.7

1.6

—

Abnormal involuntary movements

220

575

3.93

73.83

1.5

1.4

—

Alzheimer disease

355

848

3.03

73.68

1.2

1.3

—

Diffuse large B-cell lymphoma, helper endpoint

113

172

6.91

71.40

1.5

1.2

—

Diffuse large B-cell lymphoma

113

172

6.91

71.40

1.5

1.2

—

Diffuse large B-cell lymphoma, including Hilmo

113

172

6.91

71.40

1.5

1.2

—

Non-Hodgkin lymphoma, all, including Hilmo

207

536

3.97

70.42

1.7

1.3

—

Invasive ventilation

157

332

4.93

69.78

2.2

1.7

—

Brain meningioma, including Hilmo

120

201

6.27

69.05

2.0

1.3

—

Brain meningioma

117

197

6.24

66.98

2.0

1.3

—

Paraplegia, diplegia of upper limbs

10.35

60.88

2.0

1.6

—

Brain glioblastoma and astrocytoma

11.10

60.81

1.8

1.1

—

Circumscribed brain atrophy

11.10

60.38

1.1

—

Implicit fungal Sepsis, including avohilmo

121

236

5.29

58.96

1.4

1.3

—

Non-follicular lymphoma

157

379

4.27

58.95

1.8

1.4

—

Traumatic subarachnoid haemorrhage

14.48

57.21

1.6

1.1

—

Other general symptoms and signs

149

6.45

56.20

1.8

1.9

—

Motor neuron disease ALS

22.08

56.19

1.2

1.0

—

Acute lymphocytic leukaemia, including Hilmo

19.74

56.03

10.8

1.4

—

Acute lymphocytic leukaemia, helper endpoint

19.74

56.03

10.8

1.4

—

Acute lymphocytic leukaemia

19.74

56.03

10.8

1.4

—

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

110

206

5.49

55.90

1.5

1.3

—

Other and unspecified visual disturbances

176

482

3.75

55.40

1.3

1.4

—

Other and unspecified degenerative diseases of nervous system

9.18

53.08

1.5

1.1

—

Hypothyroidism (congenital or acquired)

262

475

3.12

53.02

1.3

1.2

—

Motor neuron disease (with DMD)

19.16

52.85

1.2

1.8

—

Other diseases of spinal cord

7.94

52.23

2.7

1.1

—

Viral hepatitis, IBD co-morbidity

8.73

51.28

2.2

1.2

—

Hypothyroidism and >3 levothyroxin purchases

258

474

3.08

51.24

1.3

1.2

—

Hypothyroidism, levothyroxine purchases

258

474

3.08

51.24

1.3

1.2

—

Neuromuscular dysfunction of bladder

142

360

4.05

49.92

1.6

1.4

—

Alzheimer’s disease (Late onset)

224

618

3.02

48.30

1.2

1.3

—

Use of donepezil

207

647

3.09

48.21

1.1

1.3

—

Use of rivastigmine

168

487

3.50

48.14

1.2

1.3

—

Non-Hodgkin lymphoma, all

126

6.50

47.66

1.6

1.2

—

Cerebral aneurysm, nonruptured

132

333

4.07

46.76

2.0

1.2

—

Hemiplegia

188

5.29

46.71

1.5

1.4

—

Focal brain injury

7.95

44.72

2.0

1.0

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

6.75

43.54

1.3

1.7

—

Use of teriflunomide

11.41

42.09

1.1

1.2

—

Rare circulating lymphoid malignancy, including Hilmo

107

6.68

41.73

9.3

1.2

—

Brain glioblastoma

10.57

39.70

1.6

1.0

—

Systemic atrophies primarily affecting the central nervous system

155

5.37

39.50

2.0

1.6

—

Secondary parkinsonism, excluding more controls

14.28

39.21

1.1

1.0

—

Third [oculomotor] nerve palsy

8.90

39.03

1.3

—

Brain glioblastoma, helper endpoint

9.71

37.35

1.6

1.1

—

Other lack of coordination

9.36

35.80

1.3

—

Optic atrophy

8.25

35.29

1.8

2.0

—

Optic atrophy, wide definition

8.23

35.26

1.8

2.0

—

Diseases of the myoneural junction and muscle

155

542

2.91

32.86

1.9

1.5

—

Somnolence, stupor and coma

128

5.31

32.50

1.8

1.5

—

Progressive vascular leukoencephalopathy

6.15

31.67

1.1

—

Lymphoid leukaemia

224

4.05

30.99

7.6

1.3

—

Hypothyroidism, drug reimbursement

134

295

3.21

30.71

1.4

1.1

—

Special screening examination for infectious and parasitic diseases

281

955

2.17

30.04

1.4

—

Other and unspecified paralytic syndromes

10.03

30.02

1.3

1.0

—

Monoplegia

8.34

29.71

1.3

1.4

—

Fungal Sepsis

133

4.95

29.16

1.3

—

Small fibre neuropathy

123

5.18

28.92

1.3

1.4

—

Immunodeficiency with predominantly antibody defects

105

5.58

28.80

2.2

2.0

—

Other disorders of bladder

127

430

3.00

28.56

1.4

1.3

—

Other necrotizing vasculopathies (FG)

212

3.96

28.25

1.3

1.4

—

Persons encountering health services for specific procedures, not carried out

125

427

2.99

27.76

1.3

1.5

—

Alzheimer’s disease (Atypical or mixed), excluding more controls

6.82

27.33

1.2

1.0

—

Visual impairment including blindness (binocular or monocular)

240

3.66

26.53

1.8

1.6

—

Symptoms and signs concerning food and fluid intake

103

322

3.24

26.43

1.7

1.4

—

Other disorders of nervous system

251

3.59

26.31

2.0

1.2

—

Implicit fungal Sepsis

126

4.82

26.06

1.3

—

Other and unspecified types of non-Hodgkin lymphoma, hilmo

156

4.37

25.74

1.5

1.3

—

Panhypopituitarism

7.39

25.68

2.4

1.9

—

Endovascular or surgical operations to intracerebral aneurysms

222

3.69

24.95

2.1

1.1

—

Diabetes insipidus

10.40

24.42

2.2

1.0

—

Other CVD (FINNGEN)

120

319

2.91

24.02

1.6

1.2

—

Use of memantine

209

772

2.20

23.82

1.1

1.3

—

Use of other anti-dementia drugs

209

772

2.20

23.82

1.1

1.3

—

Coxibs

241

589

2.16

23.79

1.2

1.5

—

Other disorders of binocular movement

5.58

23.74

1.8

—

Need for other prophylactic measures

291

3.25

23.47

2.3

1.7

—

Other and unspecified myopathies

102

344

3.02

23.23

2.0

1.4

—

Benign neoplasm: Brain, supratentorial

7.02

23.19

1.9

2.1

—

Failure and rejection of transplanted organs and tissues

7.50

23.16

2.6

1.5

—

Transplanted organ and tissue status

131

507

2.63

23.04

2.9

1.6

—

Other necrotizing vasculopathies

302

3.11

22.02

1.3

—

Congenital malformations of the nervous system

117

4.65

21.74

1.8

3.8

—

Thrombocytopenia, unspecified

318

3.02

21.36

2.7

1.4

—

Other acute disseminated demyelination

8.54

21.15

1.2

—

Secondary and unspecified malignant neoplasm of lymph nodes

347

2.90

21.09

1.7

1.3

—

Disorders of speech understanding and production

249

3.29

20.96

2.0

2.9

—

Use of galantamine

234

3.34

20.89

1.2

—

Other symptoms and signs involving general sensations and perceptions

116

4.50

20.87

1.2

1.8

—

Dementia in other diseases classified elsewhere

142

4.03

19.91

1.2

—

Other/unspecified cytomegaloviral diseases

5.50

19.86

2.0

1.3

—

Temporal arteritis

122

4.30

19.64

1.2

1.1

—

Other disorders of optic disc

6.65

19.02

1.3

1.1

—

Other infectious diseases

307

2.92

18.96

1.7

1.5

—

Other and unspecified immunodeficiencies with predominantly antibody defects

7.13

18.90

2.9

1.6

—

Giant cell arteritis with polymyalgia rheumatica

126

4.16

18.84

1.2

1.1

—

Cytomegalovirus infection, IBD co-morbidity

5.06

18.66

2.0

1.3

—

Explicit bacterial Sepsis, including avohilmo

101

383

2.67

18.52

1.8

1.4

—

Giant cell arteritis

150

3.83

18.50

1.2

—

Enterocolitis due to Clostridium difficile

109

430

2.57

18.48

2.0

1.5

—

Cytomegaloviral disease

4.93

18.14

1.9

1.3

—

Hypotension

144

651

2.23

17.95

1.5

1.3

—

Other intracranial haemorrhages

4.72

17.83

2.4

1.2

—

Explicit bacterial Sepsis

375

2.64

17.68

1.9

1.4

—

Other complications of surgical and medical care, not elsewhere classified

110

449

2.49

17.41

1.6

1.4

—

Use of levodopa decarboxylase inhibitor

124

534

2.35

17.39

1.2

1.3

—

Acetic acid derivatives and related substances

216

568

1.98

17.07

1.2

1.5

—

Cytomegaloviral disease, including avohilmo

4.65

16.95

1.9

1.6

—

Monoamine oxidase A inhibitors

112

467

2.43

16.91

1.2

1.4

—

Other congenital malformations of circulatory system

106

4.29

16.87

2.5

1.5

—

Diffuse brain injury

6.31

16.76

2.0

1.1

—

Other CVD

163

796

2.06

16.70

1.5

1.4

—

Psychotic depression

186

3.33

16.55

1.4

1.6

—

6-mercaptopurine

145

3.67

16.24

9.1

1.6

—

Other degenerative diseases of the basal ganglia

5.14

16.09

1.2

1.1

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

401

2.51

15.98

1.2

1.5

—

Cramp and spasm

217

3.11

15.90

1.9

1.5

—

Narcolepsy and cataplexy

23.78

15.81

1.1

1.4

—

Neuralgia and neuritis, unspecified

209

3.12

15.58

2.0

1.2

—

Adrenocortical insufficiency

155

3.51

15.45

1.4

1.8

—

Nonpyogenic thrombosis of intracranial venous system

7.36

15.43

1.3

1.1

—

Fasciculation

6.78

15.06

1.0

1.1

—

Abnormal findings in cerebrospinal fluid

26.60

14.83

1.4

—

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

164

3.36

14.82

1.4

1.2

—

Lagophthalmos

6.59

14.69

1.8

1.1

—

Immunodeficiencies

229

2.95

14.52

2.0

2.2

—

Trigeminal neuralgia

253

2.82

14.25

1.2

1.4

—

Postzoster neuralgia

5.60

14.12

1.3

1.1

—

Emotional disorders starting during childhood or adolecense, excluding more controls

183

3.12

14.10

3.1

2.3

—

Volume depletion

323

2.57

14.05

1.4

1.6

—

Unspecified dementia

259

2.65

13.67

1.3

1.2

—

Varicella [chickenpox]

211

2.95

13.51

2.0

—

Beningn neoplasm: Meninges, unspecified

5.20

13.49

2.1

1.1

—

Benign neoplasm: Spinal cord

5.52

13.37

2.1

1.1

—

Varicella [chickenpox], including avohilmo

262

2.72

13.36

2.3

—

SLE (Finngen)

121

3.63

13.31

1.3

1.9

—

Streptococcal septicaemia, including avohilmo

358

2.43

13.15

1.9

1.3

—

Viral infections of central nervous system, not elsewhere classified/unspecifie, including avohilmod

5.78

12.99

1.1

1.2

—

Use of glatiramer acetate

4.72

12.95

1.0

1.7

—

Disorders of optic nerve, not elsewhere classified

4.69

12.92

1.2

1.1

—

Other disorders of adrenal gland

211

2.90

12.92

1.5

1.9

—

Myeloid leukaemia

4.13

12.90

2.5

1.2

—

Brain astrocytoma

13.15

12.76

2.0

1.2

—

Brain astrocytoma, including Hilmo

13.15

12.76

2.0

1.2

—

Secondary parkinsonism

3.97

12.61

1.1

—

Unspecified visual impairment (binocular)

5.39

12.58

1.1

1.9

—

Undefined dementia

279

2.53

12.56

1.3

1.2

—

Decubitus ulcer and pressure area

205

2.87

12.34

2.2

1.4

—

Arnold-Chiari syndrome

5.78

12.28

1.5

2.7

—

Other specified and unspecified disorders of eye and adnexa

128

3.43

12.24

1.5

1.4

—

Streptococcal septicaemia

352

2.39

12.22

1.9

1.3

—

Brain astrocytoma, helper endpoint

11.89

12.19

2.0

1.2

—

Secondary parkinsonism+Parkinsonism in other disease

3.84

12.07

1.1

—

Personal history of malignant neoplasm

405

2.28

12.01

2.5

1.5

—

Other congenital malformations of nervous system

5.62

11.96

1.5

3.1

—

Leukaemia of unspecified cell type

9.45

11.95

6.6

1.3

—

Misadventures to patients during surgical and medical care

129

658

1.98

11.90

1.7

1.4

—

Retrobulbar neuritis in diseases classified elsewhere

15.48

11.86

1.1

1.2

—

Any operation in hilmo

14.81

11.81

1.4

1.0

—

Fenamates

116

378

2.10

11.77

1.5

—

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system, including Hilmo

11.79

11.73

2.4

1.1

—

Other/unspecified disorders of vestibular function

158

3.10

11.63

1.1

1.4

—

Autonomic disorders

4.27

11.59

1.5

1.1

—

Post-traumatic hydrocephalus, unspecified

23.49

11.57

1.9

1.3

—

Nephropathy related operations

119

597

2.02

11.55

1.5

1.6

—

Parkinson's disease, including avohilmo

123

625

1.98

11.48

1.2

1.3

—

Chondrocostal junction syndrome [Tietze]

149

3.15

11.46

1.2

1.6

—

Chorioretinal inflammation

110

3.54

11.33

1.3

1.5

—

Dementia in Alzheimer disease

104

413

2.12

11.26

1.3

—

Cauda equina syndrome

5.43

11.15

1.3

1.0

—

Disorders of muscles

444

2.16

11.13

1.3

—

Vertigo of central origin

5.39

11.13

1.3

1.1

—

Vitamin deficiency, wide

195

2.82

11.10

1.2

1.7

—

Vitamin deficiency

195

2.82

11.10

1.2

1.7

—

Secondary hypertension

283

2.46

11.07

1.3

1.5

—

Oter anti-inflammatory and antirheumatic agents, non-steroids

151

441

1.89

10.91

1.2

1.5

—

Parkinson's disease, strict definition

110

549

2.02

10.84

1.2

1.3

—

Systemic lupus erythematosus

139

3.16

10.77

1.3

1.6

—

Nonhereditary hypogammaglobulinemia

5.48

10.70

1.5

1.2

—

Hyperhidrosis

3.89

10.68

1.2

1.7

—

Encephalopathy

8.58

10.47

1.6

2.1

—

Hypoglycaemia, other or unspecified

322

2.33

10.37

1.4

2.0

—

Iridocyclitis in diseases classified elsewhere

4.21

10.23

1.3

2.2

—

Somnolence

5.44

10.19

1.8

2.1

—

Hereditary ataxia

5.17

10.13

1.3

2.6

—

Other and unspecified injuries of head

319

2.32

10.12

1.4

1.5

—

Cerebral arteritis

29.48

10.10

2.7

1.0

—

Mononeuritis multiplex

29.29

10.08

1.6

1.0

—

Thiamine deficiency

13.06

10.04

1.1

—

Internuclear ophthalmoplegia

22.01

10.03

1.6

1.1

—

Parkinson's disease

115

602

1.93

9.91

1.3

—

SLE, ICD10

136

3.08

9.87

1.3

1.5

—

SLE, strict definition

136

3.08

9.87

1.3

1.5

—

Hypersomnia

5.04

9.86

1.2

1.1

—

Other facial nerve disorders

111

3.31

9.77

1.1

1.5

—

Pain and other conditions associated with female genital organs and menstrual cycle

199

1018

1.64

9.76

1.3

1.4

—

Arthropathies in other diseases classified elsewhere

137

3.05

9.74

1.5

1.4

—

Benign neoplasm: Brain, infratentorial

9.77

9.74

2.7

2.8

—

Protozoal diseases, including avohilmo

117

3.23

9.65

1.4

1.3

—

Acute myeloid leukaemia and myelodysplastic syndromes

4.00

9.63

2.1

1.1

—

Moderate visual impairment, binocular

3.68

9.57

1.7

1.4

—

Use of peginterferon beta-1a

11.82

9.57

1.1

1.2

—

Vascular dementia

225

2.50

9.56

1.3

1.2

—

Acute renal failure

167

990

1.70

9.53

1.3

—

Protozoal diseases

113

3.26

9.51

1.4

1.2

—

Drug-induced neutropenia

348

2.22

9.48

2.1

1.3

—

Postviral fatigue syndrome

7.26

9.48

1.1

2.3

—

Other specified/unspecified necrotizing vasculopathies

4.82

9.37

1.7

1.1

—

Ptosis of eyelid

100

511

1.98

9.31

1.5

1.4

—

Gout

196

1041

1.62

9.24

1.4

—

Disorders of mineral metabolism

358

2.17

9.23

1.3

1.5

—

Other specified and unspecified strabismus

4.93

9.14

1.8

3.0

—

Carrier of infectious disease

3.48

9.10

1.4

1.7

—

Sequelae of injuries of head

241

2.44

9.07

1.8

1.5

—

Myasthenia gravis

4.30

8.98

1.7

1.3

—

Dystonia

249

2.41

8.93

1.4

1.5

—

Other and unspecified syphilis, including avohilmo

15.29

8.89

1.1

—

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

3.88

8.86

4.1

2.8

—

Pneumocystosis

4.11

8.85

1.5

1.1

—

Pneumocystosis, including avohilmo

4.11

8.85

1.5

1.1

—

Sequelae of injuries of neck and trunk

125

3.02

8.67

1.6

1.5

—

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

14.08

8.60

1.9

2.5

—

Acute mastoiditis

7.66

8.56

1.1

1.7

—

Amblyopia ex anopsia

188

2.60

8.53

1.9

2.7

—

Amenorrhoea

357

2.13

8.52

1.3

1.4

—

Disorders of brain, other and unspecified

8.85

8.39

1.4

1.1

—

Propionic acid derivatives

205

646

1.60

8.34

1.5

1.8

—

Syphilis, including avohilmo

107

3.15

8.31

1.7

1.3

—

Syphilis

107

3.15

8.31

1.7

1.3

—

Atypical virus infections of central nervous system, including avohilmo

6.76

8.31

1.5

1.1

—

Gout, FINNGEN

196

1249

1.57

8.19

1.4

1.3

—

Scleritis

4.39

8.00

1.1

1.2

—

Other disorders of peripheral nervous system

9.90

7.90

1.1

—

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

302

2.17

7.88

1.2

1.4

—

Symptoms and signs involving emotional state

3.21

7.84

1.1

2.7

—

Gout, idiopatic and unspecified

171

1076

1.60

7.81

1.3

—

Systemic lupus erythematosus, unspecified

122

2.93

7.80

1.3

1.4

—

Benign neoplasm: Spinal meninges

6.14

7.79

2.3

1.0

—

Disorder of lipoprotein metabolism, unspecified

467

1.92

7.73

1.1

1.3

—

Malignant immunoproliferative diseases

6.95

7.68

1.6

1.1

—

Implicit parasitic Sepsis, including avohilmo

12.43

7.67

1.5

1.2

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

168

1058

1.60

7.67

1.3

1.4

—

Atypical virus infections of central nervous system

6.41

7.65

1.5

1.1

—

Elevated blood glucose level

388

2.01

7.55

2.0

1.6

—

Intentional self-harm by unspecified means

4.34

7.53

1.6

1.2

—

Drug-induced polyneuropathy

6.74

7.52

10.2

2.0

—

Molar incisor enamel hypoplasia, with caries

3.83

7.51

7.6

2.4

—

Frontotemporal dementia

8.89

7.46

1.0

1.1

—

Manic episode

104

3.03

7.38

1.1

1.3

—

Tubulo-interstitial nephritis, not specified as acute or chronic

252

2.24

7.36

1.4

—

Adenomyosis (Endometriosis of uterus)

116

671

1.74

7.33

1.3

1.4

—

Congenital iodine-deficiency syndrome/hypothyroidism

3.14

7.32

1.6

2.0

—

Selective deficiency of immunoglobulin G [IgG] subclasses

7.68

7.31

1.1

1.8

—

Scleritis and episcleritis

292

2.15

7.31

1.1

1.4

—

Care involving dialysis

332

2.07

7.28

1.6

—

Collagenous colitis

435

1.93

7.28

1.4

1.5

—

Other disorders of white blood cells

241

2.27

7.27

2.6

1.5

—

Disturbances of smell and taste

127

2.79

7.24

1.3

1.4

—

Anti-inflammatory and antirheumatic products, non-steroids

199

646

1.55

7.22

1.5

1.8

—

Ulcer of vagina/vulva

122

2.84

7.21

1.1

1.7

—

Viral infections of central nervous system, not elsewhere classified/unspecified

5.79

7.15

1.2

1.3

—

Neuralgic amyotrophy

15.73

7.13

1.2

1.1

—

Acute generalized exanthematous pustulosis

193

2.42

7.13

1.7

1.8

—

Other and unspecified disorders of white blood cells

169

2.53

7.12

3.0

1.4

—

Vertical strabismus

146

2.65

7.08

2.5

1.8

—

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

135

2.72

7.04

6.9

1.8

—

Frontotemporal dementia, wide, incl. Pick's disease

7.91

7.01

1.0

1.1

—

Acute myeloid leukaemia

4.48

7.01

2.6

1.1

—

Acute myeloid leukaemia, including Hilmo

4.48

7.01

2.6

1.1

—

Acute myeloid leukaemia, helper endpoint

4.48

7.01

2.6

1.1

—

Paracetamol or NSAID medication

118

338

1.77

6.98

1.8

2.0

—

Poisoning by narcotics and psychodysleptics [hallucinogens]

3.52

6.89

3.7

1.6

—

Vascular dementia (other)

11.33

6.86

1.2

1.0

—

Other disorders involving the immune mechanism, not elsewhere classified

143

2.64

6.83

7.0

1.8

—

Cerebral palsy

3.29

6.76

3.0

2.2

—

Late syphilis, including avohilmo

3.97

6.75

1.4

1.2

—

Drug-induced adrenocortical insufficiency

3.37

6.74

1.3

1.4

—

Other and unspecified syphilis

13.35

6.73

1.1

1.0

—

Vascular dementia (subcortical)

3.24

6.71

1.3

1.1

—

Generalized epilepsy

181

2.41

6.64

1.8

2.2

—

Early syphilis

4.27

6.60

2.1

1.5

—

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

158

2.51

6.55

1.2

2.1

—

Hyperplasia of prostate

237

919

1.46

6.54

1.3

1.4

—

Helminthiases

3.72

6.51

1.3

2.0

—

Drug-induced cataract

3.12

6.51

1.7

1.6

—

Cerebral oedema

20.05

6.43

1.9

1.0

—

Outcome of delivery

146

560

1.61

6.42

1.2

1.3

—

Other specified disorders of muscle

3.01

6.41

1.1

1.3

—

Implicit parasitic Sepsis

11.58

6.38

1.5

1.2

—

Myositis

3.07

6.38

1.3

—

Dementia due to Parkinsons disease, excluding more controls

6.60

6.35

1.2

1.0

—

Polymyalgia rheumatica

523

1.77

6.28

1.3

—

Lack of expected normal physiological development

3.35

6.27

2.9

2.4

—

Emotional disorders starting during childhood or adolescence

281

2.07

6.25

3.1

2.1

—

Complications of genitourinary prosthetic devices, implants and grafts

2.95

6.19

1.6

1.5

—

Epidural haemorrhage

10.25

6.07

4.3

1.1

—

Dermatitis due to substances taken internally

247

2.13

6.06

1.7

1.6

—

Poisoning by medicine, drug-induced

3.96

6.03

1.0

1.2

—

Respiratory disorders in diseases classified elsewhere

3.96

6.03

1.2

1.1

—

Cerebral atherosclerosis

5.63

6.02

1.3

1.1

—

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

159

2.43

5.98

1.2

1.9

—

Other and unspecified disorders of binocular movement

6.72

5.96

2.9

3.5

—

Symptoms and signs involving appearance and behaviour

8.25

5.89

1.4

1.1

—

Early syphilis, including avohilmo

3.87

5.85

2.1

1.5

—

Respiratory tuberculosis, confirmed

3.84

5.84

1.4

1.2

—

Candidiasis

121

756

1.61

5.84

1.5

1.4

—

Chronic iridocyclitis

225

2.16

5.81

1.4

1.6

—

Use of amantadine

3.53

5.77

1.2

1.1

—

Other drug-induced secondary parkinsonism

5.74

1.0

1.1

—

Disorders of calcium metabolism

253

2.08

5.71

1.3

1.6

—

Gout, unspecified

134

862

1.56

5.71

1.3

—

Convergence insufficiency and excess

3.78

5.68

1.2

1.7

—

Respiratory tuberculosis, confirmed, including avohilmo

3.76

5.67

1.4

1.2

—

Hereditary hypogammaglobulinemia

13.66

5.67

2.0

1.9

—

Listeriosis

8.92

5.64

1.1

—

Listeriosis, including avohilmo

8.91

5.64

1.1

—

Excessive vomiting in pregnancy

423

1.81

5.63

1.2

1.4

—

Malignant neoplasm of meninges, including Hilmo

10.66

5.63

1.6

1.0

—

Weight loss

467

1.77

5.62

1.7

1.6

—

Osteonecrosis

282

2.01

5.62

1.9

1.4

—

Viral pneumonia (unknown virus, not influenza)

317

1.94

5.59

1.3

1.5

—

Arteriovenous malformation of cerebral vessels

3.92

5.59

2.0

1.1

—

Other and unspecified intracranial injuries

2.76

5.55

4.0

1.4

—

Spondyloarthritis

132

852

1.56

5.55

1.3

—

Hypoplasia of dental enamel

3.02

5.53

7.7

4.0

—

Status post-ami

923

0.56

5.52

1.3

—

Respiratory tuberculosis, bacteriologically and histologically confirmed

3.68

5.50

1.4

1.2

—

Malignant neoplasm of nasal cavity and sinuses

7.34

5.50

2.1

1.1

—

Use of fingolimod

5.03

5.50

1.2

1.4

—

Drug-induced systemic lupus erythematosus

5.87

5.46

1.2

1.6

—

Exophthalmic conditions

5.33

5.44

1.2

1.1

—

Disorder of the sleep-wake schedule

3.07

5.41

1.7

3.2

—

Neuromyelitis optica

12.17

5.40

1.1

1.4

—

Anomalies of pupillary function

2.91

5.39

1.1

1.5

—

Drug-induced osteoporosis with pathological fracture

3.35

5.34

2.0

1.5

—

Osteomyelitis

253

2.04

5.34

1.2

1.4

—

Effects of heat and light

6.89

5.31

1.5

1.1

—

Folate deficiency anaemia

5.15

5.30

1.1

—

Amyloidosis

3.02

5.28

1.2

1.3

—

Gonococcal infection

150

2.37

5.27

1.7

1.3

—

Cerebral amyloid angiopathy

7.71

5.22

1.3

1.1

—

Other cranial nerve disorders in other disorders

14.36

5.17

1.6

1.2

—

Other specified/unspecified dorsopathies

139

2.41

5.16

1.2

1.6

—

Hypermetropia

398

1.80

5.16

2.1

2.2

—

Kidney transplant status

271

1.98

5.14

1.5

1.8

—

Follicular lymphoma, hilmo

165

2.27

5.10

1.4

1.2

—

Hyperkinetic disorders (excl. ADHD)

126

2.48

5.09

1.4

3.1

—

Amyloidosis, other/unspecified

3.22

5.07

1.3

1.2

—

Intermittent heterotropia

328

1.88

5.06

1.8

2.5

—

Degeneration of the brain due to alcohol

2.95

5.06

1.2

—

Other maltreatment syndromes

147

2.35

5.04

1.6

1.3

—

Lesion of lateral popliteal nerve

205

2.12

5.03

1.3

1.4

—

Atrial fibrillation and flutter with reimbursement

160

683

1.48

5.02

1.2

1.3

—

Other and unspecified diseases of blood and blood-forming organs

2.67

5.01

1.3

1.2

—

Coronary artery bypass grafting

884

0.58

4.97

1.2

1.3

—

Late syphilis

4.43

4.97

1.4

1.0

—

Generalized skin eruption due to drugs and medicaments

167

2.24

4.96

1.7

1.9

—

Sequelae of inflammatory diseases of the central nervous system

8.29

4.96

1.7

1.0

—

Episcleritis

247

2.01

4.95

1.1

1.5

—

Sequelae of other external causes

261

1.97

4.93

1.5

1.4

—

Hereditary retinal dystrophy

3.55

4.92

1.6

2.1

—

Torticollis

3.27

4.92

1.2

1.5

—

Drug-induced headache, not elsewhere classified

8.00

4.90

1.9

1.1

—

Biomechanical lesions, not elsewhere classified

214

2.08

4.90

1.3

1.4

—

Behavioural disorders

2.74

4.87

1.4

2.0

—

Disorder of external ear, unspecified

143

2.34

4.87

1.2

1.5

—

Severe visual impairment, monocular

4.96

4.85

3.8

1.1

—

Osteoporosis with pathological fracture (FG)

235

2.02

4.84

1.6

1.5

—

Kela reimbursement Agammaglobulinemia (D80-84)

4.57

4.81

3.2

1.8

—

Pneumonia due to other infectious organisms, not elsewhere classified

132

2.38

4.76

1.5

—

Other and unspecified erythematous conditions

126

2.41

4.75

1.3

2.2

—

Degeneration of nervous system due to alcohol

2.83

4.74

1.2

—

Congenital hydrocephalus

7.56

4.73

3.0

3.8

—

Vulvovaginal ulceration/inflammation in other diseases

351

1.81

4.72

1.1

1.5

—

Fentanyl

373

1.78

4.67

1.5

1.4

—

Toxoplasmosis, including avohilmo

6.38

4.66

1.2

—

Unspecified misadventure during surgical and medical care

239

1.99

4.65

1.7

1.4

—

Phakomatoses, not elsewhere classified

3.42

4.65

1.6

3.0

—

Senile degeneration of the brain, not elsewhere classified

14.52

4.61

1.9

1.0

—

Helminthiases, including avohilmo

199

2.09

4.61

1.9

2.2

—

Conduct disorder

2.65

4.59

1.4

2.0

—

Uterine polyps

212

899

1.38

4.56

1.3

1.4

—

Bicipital tendinitis

187

2.11

4.53

1.5

1.3

—

Specific development disorders of scholastic skills

264

1.92

4.52

2.7

2.4

—

Unspecified event, undetermined intent

2.56

4.49

1.7

—

Malnutrition

2.81

4.47

2.6

2.7

—

Chronic conjunctivitis

130

2.34

4.45

1.4

1.8

—

Urethral stricture

195

2.07

4.44

1.4

—

Motor disorders, excluding more controls

2.69

4.43

2.5

4.7

—

Injury of nerves and spinal cord at neck level

2.66

4.42

1.4

1.2

—

Tic and related disorders

3.06

4.42

1.8

4.0

—

Unknown and unspecified causes of morbidity

182

2.10

4.41

1.2

1.4

—

Perioral dermatitis

2.59

4.41

1.5

1.3

—

Acute disseminated encephalitis/encephalomyelitis

12.83

4.38

1.4

1.0

—

Other abnormal immunological findings in serum

2.77

4.37

1.4

2.1

—

Gonococcal infection, including avohilmo

170

2.15

4.37

1.8

1.3

—

Burns classified according to extent of body surface involved

4.36

1.1

1.2

—

Hereditary motor and sensory neuropathy

5.15

4.36

1.5

2.1

—

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

3.41

4.36

1.0

1.1

—

Endocrine disorders, other/unspecified

2.93

4.36

1.4

1.2

—

Spina bifida

12.54

4.35

3.0

5.0

—

Other or unspecified paralytic strabismus

5.69

4.33

2.1

1.1

—

Hyperosmolality and hypernatraemia

4.03

4.33

1.2

1.5

—

Other specified/unspecified bacterial intestinal infections

281

1.87

4.32

1.4

1.5

—

Abnormal weight loss

429

1.69

4.30

1.3

1.6

—

Vitamin D deficiency

2.74

4.28

1.1

1.5

—

Other erythematous conditions

139

2.26

4.26

1.4

2.1

—

Respiratory insufficiency

267

1.88

4.26

2.1

1.4

—

Superficial injury of neck

2.78

4.21

1.2

1.7

—

Pruritus

563

1.59

4.20

1.6

1.4

—

Extracorporeal dialysis

270

1.87

4.18

1.6

—

Malignant neoplasm of nasal cavity and sinuses, including Hilmo

4.44

4.16

2.1

1.1

—

Rare circulating lymphoid malignancy

8.25

4.09

7.6

1.1

—

Use of antiglaucoma preparations and miotics

272

1.85

4.08

1.2

1.3

—

Occlusion and stenosis of arteries, not leading to stroke

4.69

4.07

1.3

—

Other and unspecified disorders of adult personality and behaviour

5.20

4.06

1.4

—

Dislocation, sprain and strain of joints and ligaments of thorax

149

2.17

4.04

1.3

1.6

—

Ovarian cyst

260

1136

1.31

4.03

1.4

—

Toxoplasmosis

5.77

4.02

1.2

—

Disorders of pituitary gland, other and/or unspecified

5.76

4.02

1.4

1.0

—

Prolonged pregnancy

806

0.58

4.01

1.9

1.3

—

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

143

2.19

4.00

1.3

1.5

—

Discitis, unspecified

2.86

3.98

1.1

1.3

—

Meralgia paraesthetica

144

2.18

3.94

1.1

1.4

—

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

144

2.18

3.94

1.3

1.7

—

Gastric ulcer

107

717

1.50

3.92

1.3

—

Other and unspecified injuries of wrist and hand

178

2.04

3.90

1.1

2.0

—

Other/unspecified soft tissue disorders related to use, overuse and pressure

100

2.43

3.90

1.4

1.3

—

Marginal zone B-cell lymphoma, including Hilmo

3.02

3.87

1.3

1.1

—

Other peripheral vertigo

404

1.67

3.87

1.3

—

Malignant neoplasm of nasal cavity and middle ear, including Hilmo

5.42

3.86

2.4

1.1

—

Toxic liver disease

3.11

3.83

1.5

1.6

—

Secondary thrombocytopenia

3.76

3.82

1.5

1.1

—

Dyslexia and other symbolic dysfunctions, not elsewhere classified

9.11

3.81

1.0

1.1

—

Idiopathic gout

368

1.70

3.80

1.2

1.3

—

Other and unspecified spinal muscular atrophies

4.71

3.78

1.4

1.0

—

Burn and corrosion of hip and lower limb, except ankle and foot

2.43

3.75

3.4

1.6

—

Disorders of oesophagus in diseases classified elsewhere

2.60

3.74

2.0

1.2

—

Use of riluzole

6.97

3.72

1.0

1.1

—

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

5.14

3.72

1.9

1.1

—

Mitochondrial myopathy

5.90

3.71

1.0

2.4

—

Osteonecrosis due to drugs

3.06

3.71

3.7

1.2

—

Injury of nerves and spinal cord at thorax level

6.89

3.71

1.4

1.6

—

Other bursitis of hip

2.82

3.70

2.2

1.2

—

Intracranial nontraumatic haemorrhage of fetus and newborn

6.18

3.70

4.4

8.4

—

Hypercalcemia

189

1.98

3.69

1.2

1.4

—

Explicit fungal Sepsis

5.78

3.69

1.1

—

Explicit fungal Sepsis, including avohilmo

5.78

3.69

1.1

—

Other dialysis

142

2.14

3.67

1.6

1.8

—

Other and unspecified vaccines and biological substances

4.55

3.67

1.0

1.2

—

Human immunodeficiency virus [HIV] disease

2.58

3.66

2.1

1.4

—

Personal history of other diseases and conditions

661

1.50

3.64

1.7

1.6

—

Haemorrhage, not elsewhere classified

2.49

3.63

2.2

1.2

—

Use of dimethyl fumarate

3.82

3.63

1.1

—

Other forms of systemic lupus erythematosus

4.12

3.63

1.2

1.1

—

Foreign body in genitourinary tract

3.81

3.62

1.2

—

Nightmares

8.23

3.61

1.0

1.2

—

Wegener granulomatosis

2.99

3.60

1.3

1.1

—

Sequelae of other accidents

2.99

3.59

1.4

1.2

—

Gluteal tendinitis

191

1.96

3.59

1.3

1.4

—

Malignant neoplasm of pancreas

234

0.30

3.57

1.0

1.3

—

Human immunodeficiency virus [HIV] disease, including avohilmo

2.54

3.57

2.1

1.4

—

Other inherited muscular atrophy

10.82

3.57

8.8

1.0

—

Other and unspecified injuries of shoulder and upper arm

137

2.14

3.56

1.6

1.4

—

Other and unspecified mononeuropathies of upper limb

124

2.20

3.56

1.3

1.2

—

Infection of intervertebral disc (pyogenic)

3.10

3.55

1.9

1.2

—

Gout, strict definition

106

725

1.47

3.55

1.2

1.3

—

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

4.34

3.53

1.0

1.8

—

Syndrome of inappropriate secretion of antidiuretic hormone

6.35

3.53

1.5

1.8

—

Pyogenic arthritis

257

1.80

3.50

1.3

1.5

—

Malignant neoplasm of other connective and soft tissue

2.40

3.50

1.2

1.1

—

Senility

10.07

3.50

1.0

1.3

—

Thyroiditis, ILD-related definition

550

1.54

3.48

1.4

1.5

—

Personal history of certain other diseases

2.51

3.48

1.8

1.1

—

Burns and corrosions of multiple and unspecified body regions

2.57

3.48

3.4

1.5

—

Spasmodic torticollis

132

2.15

3.47

1.2

1.7

—

Chronic hepatitis, not elsewhere classified

139

2.11

3.45

1.2

1.4

—

Myocarditis

166

2.00

3.44

1.6

1.3

—

Certain zoonotic bacterial diseases, including avohilmo

113

2.24

3.43

4.4

1.4

—

Nonalcoholic steatohepatitis

3.84

3.42

1.3

1.1

—

Flatulence and related conditions

4.15

3.41

1.3

1.6

—

Lumbosacral plexus disorders

7.35

3.41

1.9

1.0

—

Other factor of the environment

3.15

3.39

1.8

1.3

—

Perforation of oesophagus

7.22

3.39

1.3

1.0

—

Abnormal findings in nipple discharge synovial fluid wound secretions

2.88

3.38

1.3

1.2

—

Moderate visual impairment, monocular

5.93

3.38

1.3

1.1

—

Retinal detachment with retinal break

571

1.51

3.36

1.4

1.3

—

Malignant neoplasm of other connective and soft tissue, including Hilmo

175

1.96

3.35

1.1

1.4

—

Disorders of orbit

182

1.94

3.34

1.5

1.6

—

Benign neoplasm: Pineal gland

9.07

3.31

1.0

1.4

—

Superficial injuries involving multiple body regions

102

2.28

3.30

1.3

1.4

—

Thiazolidinediones

454

1.57

3.29

1.5

1.3

—

2.32

3.28

1.2

1.6

—

Oxicams

124

496

1.42

3.27

1.3

1.5

—

Multiple myeloma, including Hilmo

149

2.03

3.26

1.2

—

Thyrotropin deficiency

3.40

3.25

1.8

1.7

—

Other neurotic disorders

177

1.94

3.24

1.3

1.4

—

Viral conjunctivitis

2.41

3.24

1.6

1.7

—

Disorders of synovium and tendon in diseases classified elsewhere

2.61

3.23

1.4

1.2

—

Abnormal reflex

5.51

3.22

1.5

1.1

—

Muscle wasting and atrophy, not elsewhere classified

5.48

3.22

1.1

—

Blindness, monocular

4.25

3.21

1.2

1.3

—

Myelodysplastic syndrome

3.59

3.21

1.2

1.1

—

Malignant neoplasm of nasal cavity and middle ear

6.57

3.21

2.4

1.0

—

Hypoplasia of dental enamel , including avohilmo

233

1.80

3.21

4.8

2.7

—

Hyperkalaemia

192

1.89

3.20

1.3

—

Viral pneumonia (known virus, not influenza)

117

2.16

3.18

1.2

2.5

—

Other specified/unspecified hearing loss

388

1.61

3.16

1.3

1.4

—

Chronic myeloproliferative disease

3.31

3.16

1.2

1.1

—

Other and unspecified abdominal hernia

151

2.00

3.16

1.3

—

Malignant neoplasm of heart, mediastinum and pleura

3.00

3.15

1.5

1.1

—

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

3.00

3.15

1.5

1.9

—

Charcot foot

2.50

3.15

1.6

1.2

—

Drug-induced tremor

4.63

3.14

1.1

—

Other noninflammatory disorders of vulva and perineum

484

1.54

3.13

1.3

1.4

—

Personality and behavioural disorders due to brain disease, damage and dysfunction

3.47

3.11

2.4

1.3

—

Alcohol withdrawal state with delirium

290

1.70

3.11

1.7

1.4

—

Unspecified threat to breathing

3.25

3.08

1.2

1.5

—

Other and unspecified neuropathies

7.73

3.08

1.0

1.3

—

Pneumococcal septicemia

132

2.07

3.08

1.5

1.9

—

Other specified and unspecified retinal disorders

132

2.07

3.08

1.8

1.5

—

Disorders of male genital organs in diseases classified elsewhere

5.12

3.07

2.0

1.5

—

Additional codes for the location of defect, injury or illness

261

1.74

3.07

1.1

1.6

—

Pneumonia derived septicemia

139

2.03

3.07

1.5

1.9

—

Disorders of globe

2.46

3.06

1.7

1.4

—

Intentional self-harm by sharp object

106

2.19

3.04

1.7

1.5

—

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

2.93

3.04

1.2

1.3

—

Alzheimer’s disease (Atypical or mixed)

288

1.69

3.03

1.2

—

Assault by unspecified means

2.33

3.02

1.2

1.7

—

Exposure to other and unspecified forces of nature

4.40

3.02

1.1

1.3

—

Increased muscle tone

4.39

3.02

1.2

2.3

—

Aspergillosis

4.38

3.01

2.3

1.3

—

Other diseases of pericardium

182

1.88

3.01

1.1

1.5

—

Injury of nerves at lower leg level

3.62

3.01

1.0

1.3

—

Other acute viral hepatitis

2.80

3.01

1.0

1.4

—

Chronic lymphocytic leukaemia

100

2.22

3.00

1.3

1.2

—

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

100

2.22

3.00

1.3

1.2

—

Chronic lymphocytic leukaemia, helper endpoint

100

2.22

3.00

1.3

1.2

—

Crohn disease (strict definition, all UC cases excluded)

248

1.75

3.00

1.6

—

Injury of other and unspecified intrathoracic organs

278

1.70

3.00

1.0

1.4

—

Tic and related disorders

2.45

3.00

1.8

3.7

—

Idiopathic thrombocytopenic purpura

120

2.11

3.00

1.9

1.4

—

Other acquired deformities of musculoskeletal system and connective tissue

197

1.84

2.99

1.4

—

Neovascular glaucoma

141

2.00

2.96

2.5

1.4

—

Dialysis

191

1.85

2.94

1.5

1.8

—

Disorder of visual pathways, unspecified

7.19

2.93

4.0

3.0

—

Fourth [trochlear] nerve palsy

2.35

2.93

1.6

1.1

—

Corticotropin deficiency

3.52

2.93

2.6

1.7

—

Other congenital malformations of brain

3.85

2.92

1.5

6.3

—

Melanocytic naevi of upper limb, including shoulder

2.24

2.91

1.3

1.8

—

Congenital deformities of hip

2.24

2.91

3.3

2.6

—

Aspergillosis, including avohilmo

4.17

2.90

2.3

1.3

—

Alcohol induced polyneuropathy

3.77

2.90

1.1

1.0

—

Blindness or visual impairment, binocular

6.84

2.89

1.8

1.0

—

Molar incisor enamel hypoplasia

247

1.72

2.88

4.7

2.8

—

Use of rotigotine

3.22

2.87

1.4

1.1

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

128

944

1.36

2.87

1.4

1.3

—

Fracture of neck

259

1.71

2.87

1.1

1.4

—

Injury of unspecified body region

359

1.60

2.87

1.2

1.6

—

Injuries involving multiple body regions

164

1.91

2.86

1.2

1.6

—

Hodgkin lymphoma, hilmo

109

2.13

2.86

1.3

1.4

—

Polyarthritis, unspecified

150

1.95

2.86

1.1

1.6

—

Tobacco use

260

1.71

2.84

1.5

1.3

—

Contusion of toe(s) without damage to nail

103

2.16

2.82

1.6

1.5

—

4.53

2.81

2.9

1.9

—

Renal tubulo-interstitial disorders in diseases classified elsewhere

3.64

2.80

1.7

1.0

—

Fitting and adjustment of other devices

222

1556

1.26

2.80

1.8

1.4

—

Sequelae of intentional self-harm, assault and events of undetermined intent

4.01

2.80

1.0

2.5

—

Meningococcal infection

4.00

2.79

1.3

1.0

—

Meningococcal infection, including avohilmo

4.00

2.79

1.3

1.0

—

Exposure to excessive heat of man-made origin

3.99

2.79

1.0

1.1

—

Acrodermatitis continua

8.80

2.79

1.2

—

Anaemia in chronic diseases classified elsewhere

2.29

2.78

1.3

—

Mumps, including avohilmo

2.19

2.78

1.4

1.6

—

Melanoma in situ

173

1.87

2.78

1.1

1.4

—

Disorders resulting from impaired renal tubular function

166

1.89

2.77

1.3

1.8

—

Drug-induced dystonia

8.62

2.77

1.0

—

Presence of other devices

142

1053

1.33

2.77

1.5

1.3

—

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

413

1.54

2.77

1.2

—

Other and unspecified myoneural disorders

5.20

2.76

1.1

—

ILD and respiratory illness in diseases classified elsewhere

5.14

2.75

1.0

1.2

—

Volvulus

2.22

2.74

1.1

1.6

—

Human immunodeficiency virus [HIV] disease resulting in other conditions

2.40

2.74

2.2

1.4

—

Human immunodeficiency virus [HIV] disease resulting in other conditions, including avohilmo

2.40

2.74

2.2

1.4

—

Separation of retinal layers (serosa)

181

1.84

2.74

1.1

1.3

—

Complications of cardiac and vascular prosthetic devices, implants and grafts

2.39

2.74

1.8

1.3

—

Toxic effect of other and unspecified substances

2.75

2.73

1.8

1.7

—

Drug-induced hypoglycaemia without coma

2.74

2.73

1.6

1.7

—

Endometriosis of intestine

2.46

2.72

1.1

1.3

—

Other misadventures during surgical and medical care

2.17

2.72

1.3

1.4

—

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

2.53

2.71

1.5

1.1

—

Benign neoplasm: Rectum, anus and anal canal

125

929

1.35

2.70

1.2

1.3

—

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

381

1.56

2.69

1.3

1.2

—

Use of interferon beta-1a

2.20

2.68

1.5

—

Ingrowing nail

242

1.71

2.67

2.0

1.6

—

Contusion of ankle

190

1.80

2.67

1.8

—

Vascular dementia (undefined)

2.35

2.67

1.4

1.1

—

Contusion of toe(s) with damage to nail

2.84

2.66

1.6

1.7

—

Acquired haemolytic anaemia

2.35

2.66

1.4

—

Glaucoma secondary to other eye disorders

147

1.92

2.66

2.5

1.3

—

Tic disorders

2.43

2.65

1.9

3.8

—

Degenerative macular diseases

471

1.49

2.64

1.4

—

Anorexia

2.58

2.63

3.9

1.9

—

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

266

1.66

2.63

1.2

1.3

—

Other and unspecified medical devices associated with adverse incidents

4.80

2.62

1.6

1.1

—

Ectropion of eyelid

113

2.05

2.62

1.2

—

Disorders of other and unspecified cranial nerves

4.79

2.62

1.6

1.1

—

Asymptomatic human immunodeficiency virus [HIV] infection status

4.78

2.62

3.9

1.6

—

Infarction of spleen

4.77

2.61

2.0

1.1

—

Other and unspecified disorders of autonomic nervous system

4.15

2.60

1.3

1.1

—

Intestinal malabsorption

214

1.74

2.60

1.2

1.6

—

Rhabdomyosarcoma, including Hilmo

7.60

2.59

1.2

1.0

—

Other and unspecified injuries of ankle and foot

192

1.78

2.59

1.9

—

Other helminthiases, including avohilmo

5.73

2.58

1.5

2.0

—

Malignant neoplasm of accessory sinuses

7.47

2.58

1.6

1.0

—

Hip and thigh

7.45

2.58

1.8

1.0

—

Specific developmental disorder of motor function

111

2.05

2.57

2.5

4.9

—

Malignant neoplasm of mesothelium and soft tissue

149

1.89

2.57

1.3

1.2

—

Mumps

2.15

2.56

1.4

1.6

—

Multiple myeloma

2.15

2.55

1.1

1.2

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

2.15

2.55

1.1

1.2

—

Malignant neoplasm of urinary organs, including Hilmo

418

1.51

2.55

1.3

1.2

—

Pregnancy examination and test

120

549

1.36

2.54

1.4

1.3

—

Malignant neoplasm of pancreas, including Hilmo

315

0.44

2.52

1.0

1.3

—

Congenital deformities of hip, including avohilmo

108

2.06

2.52

3.2

2.6

—

Tuberculosis, wide

231

1.70

2.52

1.6

1.2

—

Polycythaemia vera

115

2.02

2.51

1.1

1.2

—

Paralytic ileus

136

1.93

2.51

1.4

1.6

—

Injury of nerves at shoulder and upper arm level

3.02

2.50

1.3

—

Presence of cardiac and vascular implants and grafts

172

1604

0.79

2.50

1.4

—

Entropion and trichiasis of eyelid

301

1.60

2.50

1.3

1.2

—

Macular pucker

694

1.39

2.49

1.3

1.4

—

ILD, hospital admission 2, with pulmonary infections

373

1.53

2.47

1.3

1.4

—

Other and unspecified mental retardation

122

1.99

2.47

2.6

4.4

—

Mixed disorders of conduct and emotions

130

1.95

2.47

1.3

2.3

—

Diseases of tongue

248

1.66

2.46

1.2

1.3

—

Tuberculosis, wide, including avohilmo

233

1.68

2.45

1.6

1.2

—

Other pleural conditions

374

1.53

2.45

1.5

1.4

—

Other diseases of stomach and duodenum

264

1.64

2.44

1.9

1.4

—

Carcinoma in situ of skin of other and unspecified parts of face

295

1.60

2.44

1.3

—

Use of rasagiline

2.11

2.44

1.6

1.1

—

Myocardial infarction, unclassifiable

718

0.66

2.43

1.2

1.3

—

Toxic effect of organic solvents

5.16

2.42

1.2

—

Other specified and unspecified disorders of choroid

5.16

2.42

1.0

—

Other disorders of choroid

2.93

2.42

1.0

1.8

—

Other proliferative retinopathy

5.13

2.42

2.3

1.1

—

Other renal tubulo-interstitial diseases

2.19

2.42

2.1

1.8

—

Progressive supranuclear ophthalmoplegia (Steele-Richardson-Olszewski)

5.10

2.42

1.0

1.1

—

Generalized epilepsy, mode (most common among epilepsy diagnosis)

124

1.95

2.41

1.1

2.1

—

Hepatomegaly and splenomegaly, not elsewhere classified

3.39

2.40

1.7

1.2

—

Exposure to uncontrolled fire, not in building or structure

6.56

2.40

1.0

3.1

—

Accidental poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours

6.52

2.40

1.0

2.1

—

Other mycoses, not elsewhere classified/unspecified, including avohilmo

2.37

2.40

1.1

1.3

—

Osteomyelitis of vertebra

6.45

2.39

1.0

1.4

—

Other and unspecified primary disorders of muscles

3.71

2.38

2.3

2.7

—

Simple and mucopurulent chronic bronchitis

146

1.86

2.37

2.0

2.2

—

Personal history of medical treatment

3.08

2.37

1.2

2.4

—

Benign neoplasm: Anus and anal canal

104

2.04

2.37

1.6

1.1

—

Haemorrhagic disorder due to circulating anticoagulants

3.07

2.36

1.8

1.1

—

Adjustment and management of implanted device

701

1.37

2.36

1.2

1.4

—

Synovial cyst of popliteal space [Baker]

290

1.59

2.36

1.1

1.3

—

Acidosis

2.17

2.36

1.2

2.3

—

Localized skin eruption due to drugs and medicaments

2.86

2.36

1.6

1.5

—

Other lesions of median nerve

2.16

2.35

1.1

1.2

—

Maternal care for known or suspected fetal abnormality and damage

125

803

1.32

2.35

1.2

1.3

—

Other and unspecified disorders of skin and subcutaneous tissue

267

1.62

2.35

1.3

1.4

—

Squamous cell neoplasms and carcinomas of the skin

314

1.57

2.34

1.3

1.2

—

Myelodysplastic syndrome, including Hilmo

2.10

2.33

1.2

1.1

—

Other bullous disorders

2.06

2.32

1.1

1.8

—

Other diseases of oesophagus

371

1.52

2.32

1.3

1.4

—

Other infestations, including avohilmo

2.40

2.30

1.2

2.1

—

Pedestrian injured in transport accident

316

1.56

2.30

1.2

1.4

—

Drug-induced obesity

3.00

2.30

1.1

1.7

—

Spinal osteochondrosis

2.98

2.29

1.0

1.1

—

4.73

2.29

1.0

1.1

—

Malignant neoplasm of other endocrine glands and related structures, including Hilmo

4.73

2.29

1.8

1.2

—

Mature T/NK-cell lymphomas, hilmo

2.79

2.28

1.7

1.2

—

Benign neoplasm: Other/unspecified site

2.58

2.28

1.4

1.1

—

Nephrotic syndrome

134

1.88

2.28

1.8

2.1

—

Tuberculosis, IBD comorbidity

223

1.67

2.27

1.6

1.2

—

Other specified transport accidents

3.97

2.27

1.1

1.7

—

Diaper [napkin] dermatitis

5.93

2.25

1.2

7.8

—

Monoarthritis, not elsewhere classified

171

1.77

2.25

1.3

—

Endometriosis of ovary

119

852

1.32

2.25

1.3

1.4

—

Malignant neoplasm of kidney, except renal pelvis

334

1.53

2.24

1.3

1.2

—

Benign neoplasm: Connective and other soft tissue of pelvis

5.79

2.24

1.0

1.1

—

Postdysenteric arthropathy

3.16

2.24

1.2

1.1

—

Monocytic leukaemia

5.73

2.23

1.4

1.3

—

Perineal laceration during delivery

874

0.72

2.23

1.4

1.3

—

Hypersplenism

5.69

2.23

1.6

1.2

—

Marginal zone B-cell lymphoma

2.91

2.22

1.3

1.1

—

Benign neoplasm: Other and unspecified parts of mouth

128

1.89

2.22

1.3

1.2

—

Hirsutism in women

2.22

1.3

1.2

—

Causalgia

2.44

2.21

1.2

1.7

—

Other noninfective disorders of lymphatic vessels and lymph nodes

150

1.81

2.21

1.1

1.5

—

Other puerperal infections

425

1.47

2.20

1.2

1.4

—

Other congenital malformations of respiratory system

4.58

2.20

1.7

6.2

—

Congenital dislocation of hip, unilateral

3.41

2.20

1.9

3.7

—

Disorders of magnesium metabolism

3.40

2.19

1.9

1.2

—

Autoimmune hepatitis, wide definition

180

1.73

2.19

1.3

1.7

—

Selective deficiency of immunoglobulin A [IgA]y

3.80

2.17

1.3

3.4

—

Benign neoplasm: Eye, unspecified

4.40

2.17

2.2

1.1

—

Malignant neoplasm of accessory sinuses, including Hilmo

4.40

2.17

1.7

1.0

—

Benign neoplasm: Brain, unspecified

3.77

2.17

1.3

1.2

—

Shock, not elsewhere classified

4.33

2.16

2.2

1.0

—

Injury of nerves at forearm level

2.65

2.15

1.2

1.5

—

Melanoma in situ of other and unspecified parts of face

2.82

2.15

1.1

—

Other superficial mycoses

2.02

2.11

1.7

—

therapeutic use

109

1.94

2.11

1.5

1.2

—

Other female pelvic inflammatory diseases

107

811

1.32

2.11

1.2

1.3

—

Disorder of pancreatic internal secretion, other and/or unspecified

3.26

2.11

1.0

—

Panniculitis, unspecified

3.24

2.10

1.3

1.1

—

Unspecified human immunodeficiency virus [HIV] disease, including avohilmo

2.60

2.09

2.8

1.5

—

Open wound of shoulder and upper arm

2.16

2.09

1.6

1.5

—

Other protozoal intestinal diseases, including avohilmo

2.15

2.09

1.0

2.5

—

Horner syndrome

2.59

2.09

1.7

1.1

—

Abnormal spermatozoa

488

1.42

2.09

1.2

—

Other zoonotic bacterial diseases, not elsewhere classified, including avohilmo

5.12

2.08

14.8

2.7

—

Necrotizing fasciitis

5.09

2.08

1.8

1.1

—

Lifestyle-related condition

2.74

2.08

2.0

1.3

—

Astigmatism

332

1.51

2.08

2.7

2.1

—

Embolic stroke

131

1.84

2.07

2.1

1.2

—

160

1.75

2.07

1.4

1.2

—

Multifocal fibrosclerosis

3.58

2.07

1.1

—

Thrombotic microangiopathy

3.58

2.07

1.1

1.2

—

Injury of cranial nerves

3.57

2.07

2.7

1.1

—

Other specified/unspecified disorders of bone/cartilage

110

1.93

2.06

1.2

—

Other and unspecified mononeuropathies, also in other diseases

110

1.93

2.06

1.3

1.5

—

Ehlers-Danlos syndrome, including avohilmo

2.36

2.06

1.3

1.5

—

Use of selegiline

161

1.75

2.06

1.3

1.2

—

Dyshidrosis [pompholyx]

2.35

2.06

2.8

1.4

—

Disorders of phosphorus metabolism and phosphatases

4.09

2.05

1.3

4.1

—

Other/unspecified mastoiditis and related conditions

4.09

2.05

1.0

1.2

—

Unspecified nephritic syndrome

2.19

2.05

1.1

1.2

—

Malignant neoplasm of urinary organs

366

1.48

2.04

1.3

1.2

—

Dependence on enabling machines and devices, not elsewhere classified

2.35

2.04

5.0

2.4

—

Benign neoplasm: Rectum

109

833

1.31

2.04

1.2

1.3

—

Other congenital malformations of skin

192

1.68

2.04

2.1

2.2

—

Achalasia of cardia

2.42

2.03

1.1

—

Benign neoplasm of other and unspecified sites

125

1.86

2.03

1.6

1.2

—

Other abnormal auditory perceptions

2.54

2.02

1.4

1.5

—

Other abnormalities of plasma proteins

2.53

2.02

1.7

1.1

—

Disorders in reading

2.03

2.02

5.6

2.9

—

Alopecia areata

111

1.91

2.01

1.2

2.0

—

Corneal scars and opacities

111

1.91

2.01

3.8

1.7

—

Lumbosacral root disorders, not elsewhere classified

2.85

2.01

1.7

1.0

—

ILD, hospital admissions 3, with pneumonia sepsis

311

1.52

2.00

1.4

—

Vestibular neuronitis

393

1.46

1.99

1.2

1.3

—

Personal history of risk-factors, not elsewhere classified

2.31

1.99

2.3

1.6

—

Other or ill-defined heart diseases

240

1.59

1.98

2.2

1.4

—

Other and unspecified psoriasis

312

1.51

1.98

1.2

1.4

—

Shigellosis, including avohilmo

3.39

1.97

1.1

1.2

—

Intercostal neuropathy

3.39

1.97

1.1

—

Phlebitis and thrombophlebitis of lower extremities, unspecified, drug-induced

3.38

1.97

2.6

1.1

—

Other disorders of thyroid

2.38

1.96

1.6

1.1

—

Eosinophilia

2.38

1.96

1.3

1.9

—

Other salmonella infections, including avohilmo

179

1.69

1.95

1.4

1.6

—

Certain zoonotic bacterial diseases

2.21

1.95

5.2

1.2

—

Striae atrophicae

2.60

1.95

1.4

1.2

—

Primary hyperparathyroidism

512

1.39

1.95

1.2

1.3

—

Malignant neoplasm of adrenal gland

3.85

1.95

1.8

1.1

—

Other disorders of kidney and ureter

614

1.36

1.95

1.3

1.4

—

Lesion of femoral nerve

3.02

1.95

1.1

—

Disorders of myoneural junction and muscle in diseases classified elsewhere

3.02

1.95

1.3

1.1

—

Hyperprolactinaemia, drug-induced

3.83

1.95

1.0

1.1

—

Effects of air pressure and water pressure

3.83

1.95

1.2

1.1

—

Benign neoplasm: Ill-defined sites within the digestive system

3.82

1.95

1.3

1.0

—

Other inflammation of vagina/vulva

172

1.70

1.93

1.2

1.6

—

Benign neoplasm: Adrenal gland

371

1.46

1.93

1.2

1.3

—

Prepatellar bursitis

172

1.70

1.93

1.1

1.3

—

Benign neoplasm of eye and adnexa

480

1.40

1.92

1.5

1.3

—

Car occupant injured in noncollision transport accident

150

1.75

1.91

1.0

1.4

—

Exposure to other and unspecified animate mechanical forces

128

1.81

1.90

1.3

1.7

—

Unspecified kidney failure

389

1.44

1.90

1.3

1.5

—

Abnormality of red blood cells

3.26

1.89

1.1

1.7

—

Chronic nephritic syndrome

158

1.72

1.89

1.6

1.4

—

Contact with other specified venomous animals

3.24

1.89

1.6

1.2

—

Glaucoma-related operations

204

1.63

1.89

1.2

—

Pyoderma gangrenosum

3.23

1.89

1.0

1.1

—

Need for immunization against other single viral diseases

2.18

1.89

2.6

1.3

—

Dermatitis herpetiformis

2.33

1.88

1.2

1.5

—

Glaucoma secondary to eye inflammation

2.90

1.87

1.0

1.8

—

Digestive system disorders of fetus and newborn

4.51

1.87

2.0

6.3

—

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

174

1.68

1.86

1.4

1.3

—

Polyarteritis nodosa and related conditions

2.42

1.86

1.1

1.6

—

Hepatic failure, not elsewhere classified

159

1.71

1.86

1.4

—

Tuberous sclerosis 1

4.38

1.85

1.6

6.8

—

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

3.61

1.85

2.5

1.1

—

Amoebiasis

3.60

1.85

1.2

3.8

—

Contact with hot air and gases

3.59

1.85

1.3

1.6

—

Foreign body entering into or through eye or natural orifice

409

1.43

1.83

1.4

1.7

—

Nummular dermatitis

384

1.44

1.83

1.6

1.3

—

Diseases of spleen

2.14

1.83

1.7

1.2

—

Pyoderma

2.14

1.83

1.0

1.6

—

Endocarditis

145

1.74

1.82

1.9

1.6

—

Right bundle-branch block

145

1.74

1.81

1.3

1.2

—

HSIL lesion of the vulva

2.08

1.81

1.3

1.7

—

Other protozoal intestinal diseases

2.29

1.81

1.0

2.6

—

Eosinophilic disease (BM)

2.29

1.81

1.2

1.4

—

Other and unspecified epidermal thickening

101

1.90

1.81

1.4

1.9

—

Malignant neoplasm of bone and articular cartilage

2.61

1.81

1.4

1.2

—

Diabetes mellitus in pregnancy

235

1255

1.19

1.81

1.3

1.4

—

Sexual dysfunction

2.02

1.81

2.1

1.4

—

Blepharospasm

2.80

1.80

1.1

—

ILD, hospital admissions

632

1.33

1.79

1.2

1.3

—

Intestinal adhesions without obstruction

361

1.45

1.79

1.6

1.5

—

Disorder of thyroid, unspecified

2.37

1.79

1.4

1.8

—

Malignant neoplasm of testis

2.19

1.78

1.2

1.3

—

Other diseases of gallbladder

161

1.69

1.78

1.3

1.2

—

Haemolytic anaemias

146

1.73

1.78

1.4

1.5

—

Campylobacter enteritis

109

1.85

1.78

1.1

1.7

—

Follow-up care involving plastic surgery

169

1.67

1.77

1.4

—

Respiratory tuberculosis

169

1.66

1.77

1.6

1.2

—

Respiratory tuberculosis, confirmed and not-confirmed

169

1.66

1.77

1.6

1.2

—

Metabolic disorder, other/unspecified

3.46

1.77

1.5

4.1

—

Exposure to other specified electric current

102

1.88

1.77

1.7

1.8

—

Interstitial lung disease endpoints

634

1.33

1.76

1.2

1.3

—

Interstitial lung disease

634

1.33

1.76

1.2

1.3

—

Reiter disease

3.40

1.76

1.3

1.4

—

Impaction of intestines

3.38

1.75

3.3

1.0

—

Exposure to uncontrolled fire in building or structure

3.38

1.75

1.0

1.1

—

Malignant neoplasm of small intestine

1.99

1.75

1.6

1.1

—

Retinoschisis and retinal cysts

1.99

1.75

1.1

1.4

—

Other abortion

2.54

1.75

1.1

1.2

—

Palmar fascial fibromatosis [Dupuytren]

557

1.35

1.75

1.5

1.3

—

Cardiomyopathy, other and unspecified

338

1.46

1.75

1.1

1.4

—

Habit and impulse disorders

2.24

1.74

1.8

2.4

—

Other interstitial pulmonary diseases

635

1.33

1.74

1.2

1.3

—

Presbycusis

441

1.39

1.74

1.2

—

Other and unspecified iridocyclitis

217

1.58

1.74

1.4

1.5

—

Acne conglobata

2.98

1.73

1.4

2.6

—

Carcinoma in situ of vulva

2.71

1.73

1.4

2.1

—

Migraine, unspecified, drug-induced

2.97

1.73

1.9

1.1

—

Bus occupant injured in other and unspecified transport accidents

2.97

1.73

1.0

1.2

—

Complications following abortion and ectopic and molar pregnancy

155

1.69

1.73

1.4

1.2

—

Other and unspecified injuries of forearm

2.96

1.73

1.0

2.1

—

Other and unspecified disorders of psychological development

1.99

1.72

3.0

4.8

—

Injury of blood vessels at lower leg level

3.93

1.72

1.0

1.1

—

Pedestrian injured in collision with pedal cycle

125

1.77

1.72

1.2

1.5

—

Other endocrine disorders

293

1.48

1.72

2.6

3.0

—

Infective bursitis

103

1.86

1.72

1.3

1.4

—

Congenital malformations of cardiac chambers and connections

0.00

1.72

0.0

6.1

—

Complications following infusion, transfusion and therapeutic injection

2.32

1.71

1.2

1.1

—

Patent foramen ovale

118

1.80

1.71

1.2

3.1

—

Hypertrichosis

1.93

1.70

1.3

1.2

—

Viral agents as the cause of diseases classified to other chapters

1.97

1.70

1.3

2.1

—

Contact with sharp glass

179

1.63

1.70

1.6

—

Clear cell adenocarcinoma of kidney

179

1.63

1.70

1.3

1.2

—

Tuberculosis

187

1.61

1.69

1.5

1.2

—

Lesion of radial nerve

164

1.66

1.68

1.1

1.4

—

Motor disorders

133

1.74

1.68

2.5

4.8

—

Benign neoplasm: Ascending colon

648

1.32

1.68

1.2

1.3

—

Unspecified human immunodeficiency virus [HIV] disease

2.54

1.68

3.0

1.6

—

Primary adrenocortical insufficiency

2.54

1.67

1.4

1.1

—

Disorders of porphyrin and bilirubin metabolism

2.53

1.67

2.7

1.4

—

Localized adiposity

3.22

1.67

1.0

1.1

—

Other respiratory diseases principally affecting the interstitium

762

1.29

1.67

1.3

—

Degenerative myopia

3.21

1.67

1.3

1.0

—

Acute bronchiolitis

315

1.44

1.67

2.2

2.9

—

Use of levodopa decarbox-comt-inhibitor

119

1.78

1.67

1.6

1.2

—

Other injuries of lower limb, level unspecified

2.61

1.67

1.3

1.7

—

Neurofibromatosis, type 1

2.85

1.66

1.3

1.4

—

Foreign body in ear

1.91

1.66

1.2

2.2

—

Background retinopathy and retinal vascular changes

2.11

1.66

1.4

1.2

—

Lung transplant status

2.84

1.66

2.3

2.5

—

Lung transplantation

2.84

1.66

2.3

2.5

—

Cutaneous lupus erythematosus

1.94

1.65

1.2

1.3

—

Certain conditions originating in the perinatal period

453

1.36

1.65

2.9

2.2

—

Spontaneous rupture of synovium and tendon

351

1.43

1.64

1.3

—

conjunctival haemorrhage

343

1.44

1.64

1.2

1.4

—

Transient global amnesia

360

1.42

1.63

1.2

1.4

—

Barrett oesophagus

205

1.57

1.62

1.1

1.4

—

Chronic hepatitis NAS

2.41

1.62

1.2

1.1

—

Bullous disorders

221

1.55

1.62

1.1

1.5

—

Anisometropia and aniseikonia

143

1.69

1.61

1.8

2.2

—

Other specified/unspecified soft tissue disorders

166

1.63

1.61

1.1

1.2

—

Rosacea

679

1.30

1.61

1.3

—

Multiple myeloma and malignant plasma cell neoplasms

182

1.60

1.2

1.3

—

Malignant neoplasm of testis, including Hilmo

2.02

1.60

1.2

1.3

—

Other chondrocalcinosis

2.35

1.59

1.4

1.1

—

Ovarian dysfunction, other/unspecified

2.74

1.59

1.9

1.2

—

Other salmonella infections

136

1.70

1.59

1.5

1.7

—

Anosmia

2.34

1.59

1.5

1.1

—

Overjet

143

1.68

1.59

3.2

2.9

—

Acromegaly and pituitary gigantism

3.05

1.59

1.0

1.1

—

Benign neoplasm: Bladder

2.72

1.58

1.1

—

Previous suicide attempt

2.23

1.58

1.2

1.8

—

Vascular dementia (multiple infarctions)

3.01

1.58

1.5

1.1

—

Other diseases of peritoneum

175

1.61

1.58

1.3

1.4

—

Residual foreign body in soft tissue

215

1.54

1.57

1.6

1.3

—

1.87

1.57

1.4

1.7

—

Spondylopathies in diseases classified elsewhere

2.30

1.56

1.2

1.1

—

Labour and delivery complicated by umbilical cord complications

234

0.51

1.56

1.3

—

Toxic effect of contact with venomous animals

200

1.56

1.54

1.2

1.8

—

Urethritis and urethral syndrome

1.99

1.54

1.4

1.6

—

Acute peritonitis

273

1.47

1.54

1.7

1.5

—

Polyp of the female genital tract

197

938

1.19

1.53

1.3

1.4

—

Enduring personality changes

3.41

1.53

1.0

2.2

—

Unspecified protein-energy malnutrition

3.38

1.53

1.0

1.2

—

Other and unspecified papulosquamous disorders

3.38

1.53

1.0

1.7

—

Anuria and oliguria

3.38

1.53

1.2

1.0

—

Later onset COPD

913

0.78

1.53

1.2

1.3

—

Other congenital malformations of urinary system

2.65

1.53

1.4

3.0

—

Other adrenocortical overactivity

2.64

1.52

2.3

3.6

—

Amoebiasis, including avohilmo

2.63

1.52

1.1

3.5

—

Labour and delivery complicated by fetal stress [distress]

127

1015

0.81

1.52

1.2

1.3

—

Osteopathy in diseases classified elsewhere

2.90

1.51

1.5

1.0

—

Other abnormal findings in urine

2.18

1.51

1.3

1.2

—

Benign neoplasm: Skin of lower limb, including hip

108

1.77

1.51

1.3

1.5

—

Tongue abnormality

266

1.47

1.51

1.3

1.5

—

Secondary polycythaemia

1.88

1.51

1.3

1.2

—

Family history of malignant neoplasm

590

1.31

1.50

1.3

—

Radial styloid tenosynovitis [de Quervain]

242

1.49

1.5

1.3

—

Procedures for purposes other than remedying health state

101

1.80

1.49

1.9

1.5

—

Family history of certain disabilities and chronic diseases leading to disablement

234

1.50

1.49

1.2

1.4

—

Benign neoplasm: Parotid gland

350

1.41

1.49

1.3

—

Other papulosquamous disorders

2.46

1.48

1.2

1.6

—

Use of cabergoline

2.46

1.48

2.6

1.4

—

Benign neoplasm: Caecum

470

1.35

1.48

1.2

1.3

—

Contact with sharp object, undetermined intent

109

1.76

1.47

1.9

1.4

—

Acute epiglottitis

2.24

1.47

1.3

1.2

—

Tularaemia

2.39

1.46

2.3

1.1

—

Melanocytic naevi of lower limb, including hip

203

1.54

1.46

1.3

1.6

—

Osteomalacia

2.53

1.46

1.4

1.1

—

Other epidermal thickening

179

1.57

1.46

1.7

—

Blood alcohol or alcohol intoxication level

102

1.78

1.45

1.3

1.9

—

Systemic disorders of connective tissue in diseases classified elsewhere

3.20

1.45

1.0

2.1

—

Benign neoplasm: Retina

3.17

1.44

1.2

1.1

—

Malignant neoplasm, without specification of site, including Hilmo

140

1.65

1.44

1.5

1.4

—

Epileptic seizures related to alcohol

3.17

1.44

1.2

1.5

—

Nail dystrophy

3.17

1.44

1.0

2.2

—

Autism spe, excluding more controls

102

1.77

1.44

1.1

2.8

—

Other and unspecified acne

2.05

1.44

1.9

2.1

—

Other disorders of Eustachian tube

125

1.69

1.44

1.3

1.4

—

Other and unspecified glaucoma

269

1.46

1.44

1.5

1.3

—

Unstable angina pectoris

157

1472

0.84

1.43

1.4

—

Chondromalacia

110

1.74

1.43

1.2

1.6

—

Postprocedural disorders of digestive system, not elsewhere classified

133

1.66

1.43

1.7

1.8

—

Supervision of high-risk pregnancy

143

708

1.22

1.42

1.3

1.4

—

Dysplasia of cervi uteri

164

965

1.20

1.42

1.3

1.4

—

Medial epicondylitis

149

1.62

1.41

1.1

1.2

—

Ehlers-Danlos syndrome

2.20

1.41

1.3

1.7

—

Spermatocele

262

1.46

1.41

1.9

1.3

—

Cellulitis of external ear

2.27

1.40

1.0

1.5

—

Traumatic ischaemia of muscle

2.20

1.40

1.8

1.2

—

Early complications of trauma

197

1.53

1.40

1.5

1.4

—

!Aliquae complicationes praecoces traumatis

197

1.53

1.40

1.5

1.4

—

Isolated growth hormone deficiency

2.05

1.40

2.1

5.2

—

Malignant neoplasm of head and neck, including Hilmo

380

1.37

1.40

1.3

—

Peroneal tendinitis

1.91

1.39

1.3

1.8

—

Burn and corrosion confined to eye and adnexa

1.79

1.39

1.2

1.7

—

Hypoparathyroidism

134

1.65

1.39

1.1

1.7

—

malignant neoplasm of male genital organs, including Hilmo

158

792

1.20

1.38

1.2

1.4

—

Adenocarcinoma and Papillary adenocarcinoma of kidney

2.22

1.37

1.1

—

Carcinoma in situ of skin of scalp and neck

1.81

1.37

1.9

1.1

—

Other bacterial agents as the cause of diseases classified to other chapters, including avohilmo

2.22

1.37

1.0

1.8

—

Viral agents as the cause of diseases classified to other chapters, including avohilmo

104

1.74

1.37

1.2

1.9

—

Impacted cerumen

520

1.31

1.37

1.9

1.6

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Differential panel - Cerebral spinal fluid

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS